NEUTRALIZING ANTIBODIES TO HIV-1 ENV AND THEIR USE Read more about NEUTRALIZING ANTIBODIES TO HIV-1 ENV AND THEIR USE Russia2020130795Filed on 2019-02-21
NEUTRALIZING ANTIBODIES TO HIV-1 ENV AND THEIR USE Read more about NEUTRALIZING ANTIBODIES TO HIV-1 ENV AND THEIR USE India2020037039570Filed on 2019-02-21
NEUTRALIZING ANTIBODIES TO HIV-1 ENV AND THEIR USE Read more about NEUTRALIZING ANTIBODIES TO HIV-1 ENV AND THEIR USE European Patent19709330.5Filed on 2019-02-21
NEUTRALIZING ANTIBODIES TO HIV-1 ENV AND THEIR USE Read more about NEUTRALIZING ANTIBODIES TO HIV-1 ENV AND THEIR USE China201980025868.8Filed on 2019-02-21
NEUTRALIZING ANTIBODIES TO HIV-1 ENV AND THEIR USE Read more about NEUTRALIZING ANTIBODIES TO HIV-1 ENV AND THEIR USE Canada3091437Filed on 2019-02-21
NEUTRALIZING ANTIBODIES TO HIV-1 ENV AND THEIR USE Read more about NEUTRALIZING ANTIBODIES TO HIV-1 ENV AND THEIR USE Australia2019226034Filed on 2019-02-21
COMPOSITIONS AND METHODS OF MANUFACTURING STAR POLYMERS FOR LIGAND DISPLAY AND/OR DRUG DELIVERY Read more about COMPOSITIONS AND METHODS OF MANUFACTURING STAR POLYMERS FOR LIGAND DISPLAY AND/OR DRUG DELIVERY Patent Cooperation TreatyPCT/US2020/028586Filed on 2020-04-16
CD153 AND/OR CD30 IN INFECTION Read more about CD153 AND/OR CD30 IN INFECTION US Application 16/971,144Filed on 2020-08-19
MYELIN OLIGODENDROCYTE GLYCOPROTEIN, MYELIN BASIC PROTEIN, AND PROTEOLIPID PROTEIN COMPOSITIONS AND METHODS OF USE Read more about MYELIN OLIGODENDROCYTE GLYCOPROTEIN, MYELIN BASIC PROTEIN, AND PROTEOLIPID PROTEIN COMPOSITIONS AND METHODS OF USE US Application 16/934,573Filed on 2020-07-21
EPSTEIN-BARR VIRUS VACCINES Read more about EPSTEIN-BARR VIRUS VACCINES US Patent 12,005,115Filed on 2020-07-07